Litcius/Paper detail

Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome

Jérémie Calais, Wesley R. Armstrong, Amar U. Kishan, Kiara M Booker, Thomas A. Hope, Wolfgang P. Fendler, David Elashoff, Nicholas G. Nickols, Johannes Czernin

2020European Urology Focus45 citationsDOIOpen Access PDF

Topics & Concepts

MedicineGlutamate carboxypeptidase IIProstate cancerProstatectomyPositron emission tomographyRadiation therapyRandomized controlled trialProstateSalvage therapyBiochemical recurrenceProstate-specific antigenClinical trialRadiologyNuclear medicineOncologyCancerInternal medicineChemotherapyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentStatistical Methods in Clinical Trials
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome | Litcius